APA
García-Doval I., Pérez-Zafrilla B., Ferrandiz C., Carretero G., Daudén E., de la Cueva P., Gómez-García F. J., Herrera-Ceballos E., Belinchón-Romero I., Sánchez-Carazo J. L., López-Estebaranz J., Alsina M., Ferrán M., Torrado R., Carrascosa J., Rivera R. & Vanaclocha F. (20161020). Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. : The Journal of dermatological treatment.
Chicago
García-Doval Ignacio, Pérez-Zafrilla Beatriz, Ferrandiz Carlos, Carretero Gregorio, Daudén Esteban, de la Cueva Pablo, Gómez-García Francisco J, Herrera-Ceballos Enrique, Belinchón-Romero Isabel, Sánchez-Carazo Jose Luis, López-Estebaranz Jose-Luis, Alsina Merce, Ferrán Marta, Torrado Rosa, Carrascosa Jose-Manuel, Rivera Raquel and Vanaclocha Francisco. 20161020. Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. : The Journal of dermatological treatment.
Harvard
García-Doval I., Pérez-Zafrilla B., Ferrandiz C., Carretero G., Daudén E., de la Cueva P., Gómez-García F. J., Herrera-Ceballos E., Belinchón-Romero I., Sánchez-Carazo J. L., López-Estebaranz J., Alsina M., Ferrán M., Torrado R., Carrascosa J., Rivera R. and Vanaclocha F. (20161020). Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. : The Journal of dermatological treatment.
MLA
García-Doval Ignacio, Pérez-Zafrilla Beatriz, Ferrandiz Carlos, Carretero Gregorio, Daudén Esteban, de la Cueva Pablo, Gómez-García Francisco J, Herrera-Ceballos Enrique, Belinchón-Romero Isabel, Sánchez-Carazo Jose Luis, López-Estebaranz Jose-Luis, Alsina Merce, Ferrán Marta, Torrado Rosa, Carrascosa Jose-Manuel, Rivera Raquel and Vanaclocha Francisco. Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort. : The Journal of dermatological treatment. 20161020.